Citius Pharma Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 10
Employees
  • Stock Symbol
  • CTXR
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $1.26
  • (As of Tuesday Closing)

Citius Pharma General Information

Description

Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments.

Contact Information

Website
www.citiuspharma.com
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 11 Commerce Drive
  • First Floor
  • Cranford, NJ 07016
  • United States
+1 (908) 000-0000

Citius Pharma Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Citius Pharma Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.26 $1.22 $0.41 - $1.97 $67.8M 55.6M 802K -$0.45

Citius Pharma Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2020 30-Sep-2020 FY 2019 30-Sep-2019 FY 2018 30-Sep-2018
EV 50,567 50,567 17,506 25,111
Revenue 0 0 0 0
EBITDA (17,448) (17,448) (15,597) (12,519)
Net Income (17,548) (17,548) (15,562) (12,537)
Total Assets 43,774 43,774 36,746 31,051
Total Debt 1,352 1,352 173 173
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Citius Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Citius Pharma‘s full profile, request access.

Request a free trial

Citius Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commerci
Pharmaceuticals
Cranford, NJ
10 As of 2020
000.00
000000000 000.00

00000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
000000000000000
Ingelheim am Rhein, Germany
00000 As of 0000

000000

n reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occae
0000 000000000
San Francisco, CA
0 As of 0000
0000
000000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Citius Pharma Competitors (43)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Boehringer Ingelheim Corporation Ingelheim am Rhein, Germany 00000
000000 Corporation San Francisco, CA 0 0000 000000000000 0000
000 000000 Private Equity-Backed Farmville, NC 000.00 000000000 000.00
0000000 Formerly VC-backed Fremont, CA 00 00000 000000000 00000
00000 000000 Corporation Malvern, PA 000 00000 000000 - 000 00000
You’re viewing 5 of 43 competitors. Get the full list »

Citius Pharma Executive Team (9)

Name Title Board Seat Contact Info
Myron Holubiak Chief Executive Officer & Board Member
Jaime Bartushak Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Myron Czuczman Chief Medical Officer & Executive Vice President
Gary Talarico Executive Vice President, Operations
Andrew Scott Vice President, Corporate Development and Investor Relations
You’re viewing 5 of 9 executive team members. Get the full list »

Citius Pharma Board Members (8)

Name Representing Role Since
Carol Webb Citius Pharma Board Member 000 0000
Eugene Holuka MD Citius Pharma Board Member 000 0000
Howard Safir Citius Pharma Board Member 000 0000
Leonard Mazur Self Chairman & Board Member 000 0000
Myron Holubiak Citius Pharma Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Citius Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Citius Pharma Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000-00000 0000 04-Apr-2016 000000000000000000 Biotechnology 0000000 00000
Trail One 12-Sep-2014 Merger/Acquisition 00.000 Other Consumer Products and Services
To view Citius Pharma’s complete acquisitions history, request access »